Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Why Pfizer Inc. PFE Is One of the Most Undervalued Pot Stocks to Buy

November 30, 2024
Pfizer Inc. (PFE) has been catching the attention of investors lately due to its potential as one of the most undervalued pot stocks to buy. With the legalization of marijuana in several states and the growing acceptance of its medical benefits, the demand for pot stocks has been skyrocketing. Despite being primarily known for its pharmaceutical products, Pfizer has quietly expanded its presence in the cannabis industry with its subsidiary, PfarmaCann. This strategic move has positioned Pfizer to capitalize on the booming marijuana market, making it an attractive investment opportunity for those looking to enter the pot stock sector. With its strong financials, diverse product pipeline, and a solid foothold in the cannabis industry, Pfizer Inc. (PFE) is definitely a stock worth considering for investors looking to diversify their portfolios.
If you want to leave a comment, then you need Login or Register





Other data for PFE

Related data

PFEJuly 8, 2025PFIZER INC. Hits QuantWave Price Target Forecasts with Profit of 6.75%  ~2 min.

In the latest achievement for QuantWave's forecasting platform, the stock of PFIZER INC. successfully reached the price target as predicted....

PFEJuly 2, 2025PFIZER INC. Hits QuantWave's Price Target Forecast with 6.03% Profit  ~1 min.

Pfizer Inc. stock recently hit the price target forecast by QuantWave, resulting in a profit of 6.03%. The forecast signal was generated on June 18, 2025, with a price of $23....

PFEJuly 2, 2025PFIZER INC. Hits Price Target as Predicted by QuantWave, Generating 5.63% Profit  ~1 min.

On June 20, 2025, QuantWave forecasted a long signal for PFIZER INC., with a price of 23.97 $. The target price of 25.32 $ was reached on July 2, 2025, resulting in a profit of 5.63%....

PFEJuly 2, 2025PFIZER INC. Hits Price Target Forecast on QuantWave, Realizing 8.1% Profit  ~1 min.

On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. (PFE) when the stock was trading at $23.42. Fast forward to July 2, 2025, PFIZER INC....

PFEJuly 2, 2025PFIZER INC. Stock Hits Price Target Forecast with 6.62% Profit Achievement  ~1 min.

On May 2, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. stock when it was trading at 23.75 $....

PFEJune 12, 2025PFIZER INC. Stock Reaches Price Target Forecast with a 7.16% Profit  ~2 min.

On May 28, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC.'s stock when it was priced at 23.18 $....

PFEJune 11, 2025PFIZER INC. Hits Price Target Forecast with 6.25% Profit, Validating QuantWave's Analytics  ~1 min.

PFIZER INC. has successfully reached the price target forecast set by QuantWave, signaling a profitable long position. The forecast signal was issued on 2025-05-21 when the stock was at 23.04 $....

PFEJune 10, 2025PFIZER INC. Stock Hits Price Target Forecast with 5.47% Profit - QuantWave Analysis  ~1 min.

On May 22, 2025, QuantWave issued a forecast signal for PFIZER INC. stock, predicting a long position at a price of $23.04. The target was reached on June 10, 2025, with the stock price hitting $24....

PFEJune 6, 2025PFIZER INC. PFE Partners with Acepodia, Innovating Cancer Treatments  ~1 min.

Pfizer Inc. announced a new partnership with Acepodia to develop cutting-edge cancer treatments....

PFEApril 4, 2025PFIZER INC. Hits Forecast Price Target with 7.0% Profit - QuantWave Analysis  ~1 min.

PFIZER INC. has successfully achieved the price target forecast set by QuantWave, with a profit of 7.0%. The forecast signal was issued on April 2, 2025, at a price of 24.24 $....

ABBVDecember 4, 2024ABBVIE INC.: A Leading Pharmaceutical Company with High Institutional Ownership  ~2 min.

AbbVie Inc. (NYSE: ABBV) is gaining attention in the investment world due to its high institutional ownership....

ABBVDecember 2, 2024AbbVie Inc. ABBV: A Promising Pharmaceutical Stock with Underrated Potential  ~2 min.

AbbVie Inc. (ABBV), a renowned pharmaceutical company, has been gaining attention as one of the most undervalued pot stocks in the market....

BRK-BDecember 7, 2024Berkshire Hathaway BRK.B Delivers Impressive Stock Performance and Continues to Attract Investors  ~2 min.

Berkshire Hathaway Inc. (BRK.B) has consistently operated from a strong position in the financial market, delivering impressive stock performance and attracting investor attention....

PFEJanuary 22, 2025Is Pfizer Inc. PFE the Undervalued Defensive Stock for 2025?  ~2 min.

Pfizer Inc. (NYSE:PFE) has long been one of the major players in the pharmaceutical industry....

AVGODecember 18, 2024Broadcom Crushes Q4 with 51% Revenue Surge; AI Business Skyrockets  ~1 min.

Broadcom Inc. (NASDAQ: AVGO) reported impressive financial results for the fourth quarter of 2024, surpassing expectations with a 51% surge in revenue....